Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2069681000001114 | Ontozry 25mg tablets (Arvelle Therapeutics UK) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2069691000001111 | Ontozry 25mg tablets (Arvelle Therapeutics UK) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2194701000001115 | Ontozry 25mg tablets (Angelini Pharma UK-I Limited) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2194721000001110 | Ontozry 25mg tablets (Angelini Pharma UK-I Limited) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2503391000001117 | Ontozry 25mg tablets (Angelini Pharma UK-I Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2503401000001119 | Ontozry 25mg tablets (Angelini Pharma UK-I Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ontozry 25mg tablets (Angelini Pharma UK-I Ltd) 14 tablet | Has AMP | True | Ontozry 25mg tablets (Angelini Pharma UK-I Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets